REJECTING THE PBAC GUIDELINES FOR IMAGINARY COST-EFFECTIVENESS VALUE CLAIMS: A PROPOSED NEW START FOR HEALTH TECHNOLOGY ASSESSMENT IN AUSTRALIA

Paul C. Langley, Ph.D., Adjunct Professor, College of Pharmacy, University of Minnesota, Minneapolis, MN

The Maimon Working Papers are free to download (in PDF format) at the bottom of the page.